Skip to main content
Clinical Trials/CTRI/2021/08/035736
CTRI/2021/08/035736Not yet recruitingPhase 2

Role of Incentive Spirometry in pulmonary rehabilitation of severe COVID-19 patients- an open label randomised controlled trial - RISE COVID

Dr Animesh Ray0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • a) Aged at least 18 years
  • b) Hospitalised
  • c) Confirmed SARS-CoV-2 infection by nucleic acid based testing (RT-PCR, CB-NAAT, or TrueNAT) or antigen testing
  • d) Moderate and severe COVID-19 pneumonia (SpO2 <94%)
  • e) Decreasing supplemental oxygen requirements (Nasal prongs <=6 L/min)
  • f) Hemodynamically stable
  • g) Cooperative
  • h) No medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the trial

Exclusion Criteria

  • a) MMSE <24
  • b) Recent surgery, cardiovascular event (ACS, PE)
  • c) Moderate-severe heart disease (NYHA grade III or IV)
  • d) CLD with ascites
  • e) Prior history of TB, COPD, asthma, ILD
  • f) Pregnant and lactating women
  • g) Difficulty in mobilisation (for 6MWT)
  • h) Hemodynamically unstable
  • i) Refusal of consent

Investigators

Sponsor
Dr Animesh Ray

Similar Trials